RECRUITING

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

Talk to us

Conditions

Lung Diseases

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.

Official Title

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients: a Single Center Prospective Study

Quick Facts

Study Start:2024-12-03
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06494033

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adult patients over 18 years of age
  2. 2. Lung transplant candidates with positive CMV IgG
  3. 3. Listed for lung transplantation (both double lung and single lung)
  1. 1. Negative CMV IgG prior transplant
  2. 2. Pregnant or breastfeeding women
  3. 3. HIV infected patients
  4. 4. Combined organ (e.g., lung-heart, lung-kidney) transplant candidates

Contacts and Locations

Study Contact

Yoichiro Natori, MD
CONTACT
3053556323
yxn138@med.miami.edu
Lissett Moni
CONTACT
3053555418
ltueros@med.miami.edu

Principal Investigator

Yoichiro Natori, MD
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of Miami
Miami, Florida, 33136
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Yoichiro Natori, MD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-03
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2024-12-03
Study Completion Date2026-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Diseases